Physician profile

Shital Popat

Internal Medicine · Marietta, GA

NPI 1447563572

$2,651.28

in general payments reported to CMS, 2019-2025

36 companies · $786 in 2025

The $786 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).

See the full distribution for Internal Medicine

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,798.87

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $441.84 2019-2025
Ucb, INC. $362.34 2021-2025 Bimzelx, Briviact, Zilbrysq
Lilly USA, LLC $193.07 2019-2025 Amyvid, Mounjaro, Kisunla
Pfizer INC. $151.66 2020-2025
Astellas Pharma US INC $145.21 2024-2025 Veozah
Novartis Pharmaceuticals Corporation $136.69 2019-2023
Teva Pharmaceuticals USA, INC. $106.15 2020-2025 Austedo Xr, Austedo, Austedo Xr
Novo Nordisk INC $95.62 2022-2025 Ozempic, Rybelsus, Wegovy
Alexion Pharmaceuticals, INC. $93.19 2019-2025 Ultomiris
Takeda Pharmaceuticals U.S.A., INC. $87.69 2019-2022
Genentech USA, INC. $85.16 2019-2024 Evrysdi
Greenwich Biosciences, INC. $74.77 2019-2020
Lundbeck LLC $63.19 2021-2025 Rexulti, Vyepti
Upsher-Smith Laboratories LLC $62.62 2021-2022
Impel Pharmaceuticals INC. $52.94 2023 Trudhesa
Show all 36 companies
CompanyGeneral paymentsYearsTop products
Exact Sciences Corporation $45.21 2023-2025 Cologuard Collection Kit
Scilex Pharmaceuticals INC. $42.54 2024-2025
Amgen INC. $35.65 2020-2021
Axsome Therapeutics, INC. $34.76 2025 Symbravo
Dynavax Technologies Corporation $29.00 2023 Heplisav-B
Biogen, INC. $27.25 2023 Spinraza
Boehringer Ingelheim Pharmaceuticals, INC. $26.18 2024
Corcept Therapeutics $25.48 2023 Korlym
Genzyme Corporation $24.09 2019
Acorda Therapeutics, INC $22.78 2019
Sanofi-Aventis U.S. LLC $22.72 2024
Janssen Biotech, INC. $22.34 2024 Tremfya
Ge Healthcare $22.00 2025
E.R. Squibb & Sons, L.L.C. $19.00 2025 Orencia
Biohaven Pharmaceutical Holding Company LTD. $18.02 2022
Glaxosmithkline, LLC. $17.69 2024 Benlysta
Promius Pharma LLC $17.42 2019
Shire North American Group INC $12.43 2019
Sanofi Pasteur INC. $12.10 2019
Sunovion Pharmaceuticals INC. $11.66 2021
Merck Sharp & Dohme LLC $10.82 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Shital Popat

$2,651.28

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbvie INC.
Context
The $786 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).

https://glasscript.com/doctor/632076/shital-popat

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.